Working... Menu

The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01484704
Recruitment Status : Unknown
Verified November 2011 by Turku University Hospital.
Recruitment status was:  Recruiting
First Posted : December 2, 2011
Last Update Posted : December 2, 2011
Information provided by (Responsible Party):
Turku University Hospital

Brief Summary:
The purpose of this study is to determine how MRI changes the treatment and diagnostics of ductal breast cancer. 100 women with newly diagnosed breast cancer will participate the study.

Condition or disease
Mammary Ductal Carcinoma

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Case Control
Time Perspective: Prospective
Study Start Date : February 2011

Resource links provided by the National Library of Medicine

No treatment

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Newly diagnosted breast cancer patients

Inclusion Criteria:

  • Tumor size less than 2cm
  • Ductal carcinoma unifocal

Exclusion Criteria:

  • Previous breast cancer

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01484704

Layout table for location contacts
Contact: Nina M Brück, MD +35823130544

Layout table for location information
University hospital of Turku Recruiting
Turku, Finland, 20521
Contact: Nina M Brück, MD   
Principal Investigator: Nina M Brück, MD         
Sponsors and Collaborators
Turku University Hospital

Layout table for additonal information
Responsible Party: Turku University Hospital Identifier: NCT01484704     History of Changes
Other Study ID Numbers: 63/180/2010
First Posted: December 2, 2011    Key Record Dates
Last Update Posted: December 2, 2011
Last Verified: November 2011

Keywords provided by Turku University Hospital:
Carcinoma ductale mammae

Additional relevant MeSH terms:
Layout table for MeSH terms
Carcinoma, Ductal
Carcinoma, Ductal, Breast
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms, Ductal, Lobular, and Medullary
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases